Literature DB >> 11344888

A seat at the table: membership in federal advisory committees evaluating public policy in genetics.

C F Ard1, M R Natowicz.   

Abstract

OBJECTIVES: This study examined who participates in federal government advisory committees regarding public policy in human and medical genetics, what parties they represent, and to what extent the general public is meaningfully represented.
METHODS: Analysis focused on 7 federal government documents published from January 1990 to February 1995. Advisors were categorized into 4 groups based on the professional affiliations that were listed in the publications. After a search of several references and data-bases, the study examined whether these individuals also had other affiliations not listed in the government publications.
RESULTS: Individuals whose principal affiliations were with academia (n = 32; 44%) or industry (n = 19; 26%) represented nearly three fourths of the sample, followed by government employees (n = 13; 18%) and consumer advocates (n = 8; 11%). At least 16% of the advisors serving on the federal committees, mostly members of academia, had a dual affiliation.
CONCLUSIONS: These data indicate that the public has modest representation on key federal advisory committees making policy recommendations regarding human genetics technology and clinical practice and that there is ample room for additional public participation.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach; Genetics and Reproduction

Mesh:

Year:  2001        PMID: 11344888      PMCID: PMC1446679          DOI: 10.2105/ajph.91.5.787

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  12 in total

1.  Shattuck lecture--medical and societal consequences of the Human Genome Project.

Authors:  F S Collins
Journal:  N Engl J Med       Date:  1999-07-01       Impact factor: 91.245

2.  A case for public participation in science policy formation and practice.

Authors:  Halsted R Holman; Diana B Dutton
Journal:  South Calif Law Rev       Date:  1978-09

3.  The place of the public in the conduct of science.

Authors:  Marc Lappé; Patricia A Martin
Journal:  South Calif Law Rev       Date:  1978-09

4.  The commercialization of clinical genetics: an analysis of interrelations between academic centers and for-profit clinical genetics diagnostics companies.

Authors:  Marvin R Natowicz; Catherine Ard
Journal:  J Genet Couns       Date:  1997-09       Impact factor: 2.537

5.  A national dialogue on genetics and minority issues.

Authors:  Ilana Suez Mittman; Marion Gray Secundy
Journal:  Community Genet       Date:  1998

6.  The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials.

Authors:  Steven Epstein
Journal:  Sci Technol Human Values       Date:  1995

7.  Individual, family, and societal dimensions of genetic discrimination: a case study analysis.

Authors:  Lisa N Geller; Joseph S Alper; Paul R Billings; Carol I Barash; Jonathan Beckwith; Marvin R Natowicz
Journal:  Sci Eng Ethics       Date:  1996-01       Impact factor: 3.525

8.  Technology policy and democracy.

Authors:  B M Casper
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

9.  Patients in research: not just subjects, but partners.

Authors:  S J Heymann
Journal:  Science       Date:  1995-08-11       Impact factor: 47.728

Review 10.  Patient accountability and quality of care: lessons from medical consumerism and the patients' rights, women's health and disability rights movements.

Authors:  M A Rodwin
Journal:  Am J Law Med       Date:  1994
View more
  3 in total

1.  Community involvement in developing policies for genetic testing: assessing the interests and experiences of individuals affected by genetic conditions.

Authors:  Sarah E Gollust; Kira Apse; Barbara P Fuller; Paul Steven Miller; Barbara B Biesecker
Journal:  Am J Public Health       Date:  2005-01       Impact factor: 9.308

2.  Concerns of newborn blood screening advisory committee members regarding storage and use of residual newborn screening blood spots.

Authors:  Erin W Rothwell; Rebecca A Anderson; Matthew J Burbank; Aaron J Goldenberg; Michelle Huckaby Lewis; Louisa A Stark; Bob Wong; Jeffrey R Botkin
Journal:  Am J Public Health       Date:  2011-02-17       Impact factor: 9.308

3.  Residual newborn screening samples for research: parental information needs for decision-making.

Authors:  Erin Rothwell; Lauren Clark; Rebecca Anderson; Jeffrey R Botkin
Journal:  J Spec Pediatr Nurs       Date:  2013-03-05       Impact factor: 1.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.